REPORTS

Let’s Pullulate and Expand Your Business

Pharmaceutical Drugs for Therapy Market - Global Professional Analysis and Forecast to 2026

Oct 20, 2019  |  186 PAGES  |  REPORT CODE: CMM218781
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Pharmaceutical Drugs for Therapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.3% during the forecast period.

This report presents the market size and development trends by detailing the Pharmaceutical Drugs for Therapy market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pharmaceutical Drugs for Therapy market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pharmaceutical Drugs for Therapy industry and will help you to build a panoramic view of the industrial development.

Pharmaceutical Drugs for Therapy Market, By Type:

  • Diabetics Drugs

  • Cardiovascular Drugs

  • Oncology Drugs

  • Pain and Wound Management Drugs

  • Dermatology Drugs

  • Neurology Drugs

  • Others

Pharmaceutical Drugs for Therapy Market, By Application:

  • Hospital

  • Clinic

  • Drug Stores

  • Others

Some of the leading players are as follows:

  • Astellas Pharma

  • Aspen

  • Pfizer Inc.

  • Abbott Laboratories

  • GSK

  • Gulf Pharmaceutical Industries (Julphar)

  • Eli Lilly and Company

  • Bayer

  • Adcock Ingram

  • Boehringer Ingelheim

  • AstraZeneca

  • Merck & Co.

  • Novo Nordisk

  • Novartis

  • AbbVie

  • GlaxoSmithKline

  • 3M Pharmaceuticals

  • Amgen

  • Saudi Pharmaceutical Industries and Medical Appliances Corporation

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Pharmaceutical Drugs for Therapy Market: Technology Type Analysis

  • 4.1 Pharmaceutical Drugs for Therapy Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Pharmaceutical Drugs for Therapy Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Diabetics Drugs

    • 4.3.2 Cardiovascular Drugs

    • 4.3.3 Oncology Drugs

    • 4.3.4 Pain and Wound Management Drugs

    • 4.3.5 Dermatology Drugs

    • 4.3.6 Neurology Drugs

    • 4.3.7 Others

5 Pharmaceutical Drugs for Therapy Market: Product Analysis

  • 5.1 Pharmaceutical Drugs for Therapy Product Market Share Analysis, 2018 & 2026

  • 5.2 Pharmaceutical Drugs for Therapy Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Pharmaceutical Drugs for Therapy Market: Application Analysis

  • 6.1 Pharmaceutical Drugs for Therapy Application Market Share Analysis, 2018 & 2026

  • 6.2 Pharmaceutical Drugs for Therapy Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital

    • 6.3.2 Clinic

    • 6.3.3 Drug Stores

    • 6.3.4 Others

7 Pharmaceutical Drugs for Therapy Market: Regional Analysis

  • 7.1 Pharmaceutical Drugs for Therapy Regional Market Share Analysis, 2018 & 2026

  • 7.2 Pharmaceutical Drugs for Therapy Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Astellas Pharma

    • 9.1.1 Astellas Pharma Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Aspen

    • 9.2.1 Aspen Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Pfizer Inc.

    • 9.3.1 Pfizer Inc. Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Abbott Laboratories

    • 9.4.1 Abbott Laboratories Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 GSK

    • 9.5.1 GSK Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Gulf Pharmaceutical Industries (Julphar)

    • 9.6.1 Gulf Pharmaceutical Industries (Julphar) Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Eli Lilly and Company

    • 9.7.1 Eli Lilly and Company Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Bayer

    • 9.8.1 Bayer Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Adcock Ingram

    • 9.9.1 Adcock Ingram Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Boehringer Ingelheim

    • 9.10.1 Boehringer Ingelheim Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 AstraZeneca

    • 9.11.1 AstraZeneca Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Merck & Co.

    • 9.12.1 Merck & Co. Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Novo Nordisk

    • 9.13.1 Novo Nordisk Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Novartis

    • 9.14.1 Novartis Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 AbbVie

    • 9.15.1 AbbVie Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 GlaxoSmithKline

    • 9.16.1 GlaxoSmithKline Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 3M Pharmaceuticals

    • 9.17.1 3M Pharmaceuticals Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Amgen

    • 9.18.1 Amgen Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Saudi Pharmaceutical Industries and Medical Appliances Corporation

    • 9.19.1 Saudi Pharmaceutical Industries and Medical Appliances Corporation Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

 

The List of Tables and Figures (Totals 91 Figures and 151 Tables)

  • Figure Diabetics Drugs Pharmaceutical Drugs for Therapy market, 2015 - 2026 (USD Million)

  • Figure Cardiovascular Drugs Pharmaceutical Drugs for Therapy market, 2015 - 2026 (USD Million)

  • Figure Oncology Drugs Pharmaceutical Drugs for Therapy market, 2015 - 2026 (USD Million)

  • Figure Pain and Wound Management Drugs Pharmaceutical Drugs for Therapy market, 2015 - 2026 (USD Million)

  • Figure Dermatology Drugs Pharmaceutical Drugs for Therapy market, 2015 - 2026 (USD Million)

  • Figure Neurology Drugs Pharmaceutical Drugs for Therapy market, 2015 - 2026 (USD Million)

  • Figure Others Pharmaceutical Drugs for Therapy market, 2015 - 2026 (USD Million)

  • Figure Hospital market, 2015 - 2026 (USD Million)

  • Figure Clinic market, 2015 - 2026 (USD Million)

  • Figure Drug Stores market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Pharmaceutical Drugs for Therapy market, by country, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table North America Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Canada Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Drugs for Therapy market, by country, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Europe Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Germany Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table France Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Italy Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Spain Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Drugs for Therapy market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table China Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Japan Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table India Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Drugs for Therapy market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Drugs for Therapy market, by country, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table MEA Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Pharmaceutical Drugs for Therapy market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Drugs for Therapy market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Pharmaceutical Drugs for Therapy market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Astellas Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aspen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GSK Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Gulf Pharmaceutical Industries (Julphar) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Adcock Ingram Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck & Co. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table 3M Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amgen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Saudi Pharmaceutical Industries and Medical Appliances Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top